morning rico!
Sentiment: Strong Buy
morning gary!
Sentiment: Strong Buy
Long and strong, she's moving up!
Sentiment: Strong Buy
Long and strong
Sentiment: Strong Buy
Adding here!
Sentiment: Strong Buy
hello peeps!
Sentiment: Strong Buy
morning Z!
Sentiment: Strong Buy
ditto
Sentiment: Strong Buy
bust a nut FOLD! -eop
Sentiment: Strong Buy
the uptrend on the weekly is broke, without news she'll trickle down
Sentiment: Strong Buy
just oversold
Sentiment: Strong Buy
Git-r-done!
dude, the markets are going to roll over
it's a buying opp
Sentiment: Strong Buy
it's in the bag
Sentiment: Strong Buy
Sarepta price target raised to $50 from $35 at Piper Jaffray
Piper Jaffray believes the FDA's request for additional information bodes well for accelerated approval of eteplirsen. The firm sees increased likelihood that Sarepta will be able to file an application for eteplirsen later this year and raised its price target for shares to $50 from $35. Piper reiterates an Overweight rating on Sarepta, whose shares were downgraded this morning at Leerink.
Sentiment: Strong Buy
no so fast octowoman
Sentiment: Strong Buy
http://finance.yahoo.com/news/sarepta-therapeutics-announces-fda-consider-201020560.html
Sentiment: Strong Buy
Oh ya and the state
Sentiment: Strong Buy
morning rico, any day now
Sentiment: Strong Buy